Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus for Left Ventricular Hypertrophy in Kidney Transplant Recipients
NCT02493465Phase 4Unknown
- Sponsor
- Instituto de Urologia e Nefrologia
- Start
- Jul 2015
- Primary completion
- Jul 2016
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of everolimus in left ventricular hypertrophy (LVH), sponsored by Instituto de Urologia e Nefrologia. Primary endpoint: Progression of left ventricular hypertrophy at 12 months. Status: unknown.
02
Drugs
everolimus
03
Conditions
left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on NCT02493465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02493465.